Althea Group Holdings Ltd (ASX: AGH) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Althea Group Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Althea Group Holdings Ltd (ASX: AGH)
Latest News
Share Fallers
Why Althea, Altium, Fortescue, & Retail Food Group are dropping lower

Share Gainers
Why cannabis company Althea (ASX:AGH) is storming higher today
Share Market News
Why the Althea (ASX:AGH) share price soared 6% today

Share Market News
Why the Althea (ASX:AGH) share price is climbing higher today
Share Gainers
Why Althea, BWX, Damstra, & GrainCorp shares are charging higher

Share Market News
Althea (ASX:AGH) share price on watch following 2 new agreements

Share Market News
ASX stock of the day: Elixinol Global (ASX:EXL) shares blaze new highs

Share Market News
Here's why ASX cannabis shares are falling today

Healthcare Shares
How did ASX cannabis shares perform last quarter?

Share Market News
Why is the Althea (ASX:AGH) share price up 8% today?
Share Market News
Is it time to buy into these three ASX cannabis shares?

Share Market News
Althea (ASX:AGH) share price surges 11% on Canadian cannabis licence
AGH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|
About Althea Group Holdings Ltd
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, andCorporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into geographic segments: Australia, the United Kingdom, Canada, Germany and Ireland. The company earns key revenue from Australia and through the sale of medicinal cannabis products.
AGH Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
07 May 2025 | $0.03 | $0.00 | 0.00% | 1,036,908 | $0.02 | $0.03 | $0.02 |
06 May 2025 | $0.02 | $0.00 | 0.00% | 482,891 | $0.02 | $0.02 | $0.02 |
05 May 2025 | $0.02 | $0.00 | 0.00% | 4,545 | $0.02 | $0.02 | $0.02 |
02 May 2025 | $0.02 | $0.00 | 0.00% | 901,301 | $0.02 | $0.02 | $0.02 |
01 May 2025 | $0.02 | $0.00 | 0.00% | 59,766 | $0.02 | $0.02 | $0.02 |
30 Apr 2025 | $0.02 | $0.00 | 0.00% | 3,230,549 | $0.02 | $0.02 | $0.02 |
29 Apr 2025 | $0.02 | $0.00 | 0.00% | 290,721 | $0.02 | $0.02 | $0.02 |
28 Apr 2025 | $0.02 | $0.00 | 0.00% | 637,126 | $0.02 | $0.02 | $0.02 |
24 Apr 2025 | $0.02 | $0.00 | 0.00% | 82,638 | $0.02 | $0.02 | $0.02 |
23 Apr 2025 | $0.02 | $0.00 | 0.00% | 28,678 | $0.02 | $0.02 | $0.02 |
22 Apr 2025 | $0.02 | $0.00 | 0.00% | 292,703 | $0.02 | $0.02 | $0.02 |
17 Apr 2025 | $0.02 | $0.00 | 0.00% | 230,454 | $0.02 | $0.02 | $0.02 |
16 Apr 2025 | $0.02 | $0.00 | 0.00% | 899,754 | $0.02 | $0.02 | $0.02 |
15 Apr 2025 | $0.02 | $0.00 | 0.00% | 1,805,922 | $0.02 | $0.02 | $0.02 |
14 Apr 2025 | $0.02 | $0.00 | 0.00% | 1,517,104 | $0.02 | $0.02 | $0.02 |
11 Apr 2025 | $0.02 | $0.00 | 0.00% | 45,669 | $0.02 | $0.02 | $0.02 |
10 Apr 2025 | $0.02 | $0.00 | 0.00% | 14,061 | $0.02 | $0.02 | $0.02 |
09 Apr 2025 | $0.02 | $0.00 | 0.00% | 374,552 | $0.02 | $0.02 | $0.02 |
08 Apr 2025 | $0.02 | $0.00 | 0.00% | 357,968 | $0.02 | $0.02 | $0.02 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
29 Apr 2025 | Vaughan Webber | Issued | 1,000,000 | $20,000 |
Placement.
|
29 Apr 2025 | Matt Adams | Issued | 1,000,000 | $20,000 |
Placement.
|
29 Apr 2025 | Joshua Fegan | Issued | 4,000,000 | $80,000 |
Placement.
|
29 Apr 2025 | Joshua Fegan | Issued | 2,601,564 | $59,375 |
Issue of securities. Non-cash
|
11 Mar 2025 | Alan Boyd | Transfer | 113,718 | $2,729 |
Off-market transfer. Nil cash (Transfer to closely related entities).
Estimated value, As per announcement on 14-03-2025 |
17 Feb 2025 | Vaughan Webber | Issued | 697,674 | $30,000 |
Issue of securities. Non-cash,697,674 Performance Rights
|
17 Feb 2025 | Joshua Fegan | Expiry | 300,571 | $27,680 |
As advised by the company. Lapsed, 80,09,766 Rights
|
17 Feb 2025 | Joshua Fegan | Issued | 2,799,419 | $128,750 |
Issue of securities. 10,809,185 Performance Rights
|
01 Nov 2024 | Vaughan Webber | Buy | 1,000,000 | $44,485 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Alan Maclean Boyd | Non-Executive Director | Jun 2018 |
Mr Boyd started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors. He is Chair of the Risk and Compliance Management Committee.
|
Mr Vaughan Webber | Non-Executive ChairmanNon-Executive Director | Aug 2024 |
Mr Webber is a company director and finance executive with over 20 years of experience, His career highlights include Non-Executive Director, HUB24 Ltd (ASX:HUB) (2012-2018), Independent Chairman, Wentworth Holdings Ltd (ASX:WWM) (2009-2013) ,Ltd (ASX:TOP) Independent Chairman, Solvar Ltd (ASX:SVR) (2014-2016), Non-Executive Director, Anchor Resources Ltd (ASX:AHR) (2011-2019). Mr Webber currently holds a number of Board roles including Chairman in the private sector.
|
Mr Matt John Adams | Non-Executive Director | Feb 2025 |
Mr Adams has 25 years of executive-level experience across corporate finance, restructuring, and turnaround sectors. He has held senior leadership positions, including CEO, CFO, and CRO roles for both listed and unlisted entities. He is currently the Managing Director of Dynamic Corporate Investments, a boutique corporate finance firm specialising in restructuring, corporate advisory, and investment. Mr Adams background in financial structuring, governance, and risk management.
|
Mr Joshua Michael Fegan | Chief Executive OfficerManaging Director | Jun 2018 |
Mr Fegan is the founder of Althea Group Holdings Limited and has experience in business building, sales and marketing. He has a range of business and strategy skills and has previously held a number of senior management roles at national value-based retailer, Strathfield Group.
|
Mr Adam John Gallagher | Company Secretary | Dec 2024 |
-
|
Adam John Gallagher | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Adman Lanes Pty Ltd | 60,000,000 | 14.76% |
Joshua Michael Fegan | 57,444,030 | 14.13% |
UBS Nominees Pty Ltd | 10,769,451 | 2.65% |
Citicorp Nominees Pty Limited | 10,558,096 | 2.60% |
Mancann Pty Ltd | 10,000,000 | 2.46% |
Hootch Pty Ltd | 7,500,000 | 1.85% |
Hunt Prosperity Pty Ltd Investius PB Micro Cap A/C> | 7,500,000 | 1.85% |
Hosanda Corporation Pty Limited | 6,500,000 | 1.60% |
Mr Thomas Mark Nowak | 5,000,000 | 1.23% |
HSBC Custody Nominees (Australia) Limited | 4,807,529 | 1.18% |
Pither Investments Pty Ltd Pither Investments A/C> | 4,800,000 | 1.18% |
Rizzo Super Pty Ltd Rizzo Super Fund A/C> | 4,500,000 | 1.11% |
McLennan Trading Pty Ltd | 4,100,000 | 1.01% |
Kevevans Pty Ltd | 3,850,000 | 0.95% |
Vidog Capital Pty Ltd | 3,770,834 | 0.93% |
Mr Orlando Alfredo Guerra Curvelo | 3,500,000 | 0.86% |
Mrs Nola Kendall Fletcher | 3,250,000 | 0.80% |
Nintieth Y Pty Ltd I K Cldwell & Co Staff A/C> | 3,000,000 | 0.74% |
HSBC Custody Nominees (Australia) Limited A/C 2 | 2,952,629 | 0.73% |
Mr Hooi Giap Toh Yang and Toh Family A/C> | 2,500,000 | 0.62% |